Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Mar;71(3):579–586. doi: 10.1172/JCI110803

Role of calmodulin in thyroid hormone stimulation in vitro of human erythrocyte Ca2+-ATPase activity.

F B Davis, P J Davis, S D Blas
PMCID: PMC436906  PMID: 6219128

Abstract

Because human erythrocyte membrane Ca2+-ATPase is a calmodulin-dependent enzyme, and because physiological levels of thyroid hormone stimulate this enzyme system in vitro, we have studied the role of calmodulin in this model of extranuclear thyroid hormone action. Ca2+-ATPase activity in the absence of thyroid hormone ("basal activity") was increased by inclusion in the preassay incubation mixture of purified calmodulin or hypothyroid erythrocyte hemolysate that contained calmodulin (39 micrograms calmodulin/ml packed cells, determined by radioimmunoassay); addition of L-thyroxine or 3,5,3'-triiodo-L-thyronine (10(-10)M) significantly enhanced (P less than 0.001) enzyme activity in the presence of calmodulin or hemolysate. The stimulatory effects of thyroid hormone, calmodulin, and hemolysate were additive. At 5-10 microM, trifluoperazine, an antagonist of calmodulin, inhibited thyroid hormone stimulation of Ca2+-ATPase activity. Higher concentrations of trifluoperazine (50-100 microM) inhibited basal and hormone-stimulated enzyme activity, with or without added calmodulin. Anti-calmodulin antibody (10-50 micrograms antibody/mg membrane protein) inhibited basal, calmodulin-stimulated and thyroid hormone-stimulated Ca2+-ATPase activity. Membrane preparations were shown by radioimmunoassay to contain residual endogenous calmodulin (0.27 +/- 0.02 micrograms/mg membrane protein). The latter accounts for the effect of trifluoperazine and calmodulin antibody on membrane Ca2+-ATPase activity in the absence of added purified calmodulin. These results support the conclusion that the in vitro action of physiological levels of iodothyronines on human erythrocyte Ca2+-ATPase activity requires the presence of calmodulin.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chafouleas J. G., Dedman J. R., Munjaal R. P., Means A. R. Calmodulin. Development and application of a sensitive radioimmunoassay. J Biol Chem. 1979 Oct 25;254(20):10262–10267. [PubMed] [Google Scholar]
  2. Chopra I. J. A radioimmunoassay for measurement of thyroxine in unextracted serum. J Clin Endocrinol Metab. 1972 Jun;34(6):938–947. doi: 10.1210/jcem-34-6-938. [DOI] [PubMed] [Google Scholar]
  3. Davis F. B., Kite J. H., Jr, Davis P. J., Blas S. D. Thyroid hormone stimulation in vitro of red blood cell Ca2+-ATPase activity: interspecies variation. Endocrinology. 1982 Jan;110(1):297–298. doi: 10.1210/endo-110-1-297. [DOI] [PubMed] [Google Scholar]
  4. Davis P. J., Blas S. D. In vitro stimulation of human red blood cell Ca2+-ATPase by thyroid hormone. Biochem Biophys Res Commun. 1981 Apr 30;99(4):1073–1080. doi: 10.1016/0006-291x(81)90728-2. [DOI] [PubMed] [Google Scholar]
  5. Davis P. J., Davis F. B., Blas S. D. Studies on the mechanism of thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity. Life Sci. 1982 Feb 15;30(7-8):675–682. doi: 10.1016/0024-3205(82)90283-1. [DOI] [PubMed] [Google Scholar]
  6. Davis P. J., Yoshida K., Schoenl M. Interaction of thyroid hormone and hemoglobin. I. Nature of the interaction and effect of hemoglobin on thyroid hormone radioimmunoassay. J Lab Clin Med. 1980 May;95(5):714–724. [PubMed] [Google Scholar]
  7. Dedman J. R., Welsh M. J., Means A. R. Ca2+-dependent regulator. Production and characterization of a monospecific antibody. J Biol Chem. 1978 Oct 25;253(20):7515–7521. [PubMed] [Google Scholar]
  8. Farrance M. L., Vincenzi F. F. (Ca-Mg)ATPase activity of human erythrocyte membranes: influence of incubation buffer. Experientia. 1977 Jul 15;33(7):865–866. doi: 10.1007/BF01951248. [DOI] [PubMed] [Google Scholar]
  9. Galo M. G., Uñates L. E., Farías R. N. Effect of membrane fatty acid composition on the action of thyroid hormones on (Ca2+ + Mg2+)-adenosine triphosphatase from rat erythrocyte. J Biol Chem. 1981 Jul 25;256(14):7113–7114. [PubMed] [Google Scholar]
  10. Goldfine I. D., Simons C. G., Ingbar S. H. Stimulation of the uptake of alpha-aminoisobutyric acid in rat thymocytes by L-triiodothyronine: a comparison with insulin and dibutyryl cyclic AMP. Endocrinology. 1975 Mar;96(3):802–805. doi: 10.1210/endo-96-3-802. [DOI] [PubMed] [Google Scholar]
  11. Jarrett H. W., Penniston J. T. Purification of the Ca2+-stimulated ATPase activator from human erythrocytes. Its membership in the class of Ca2+-binding modulator proteins. J Biol Chem. 1978 Jul 10;253(13):4676–4682. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Luthra M. G., Au K. S., Hanahan D. J. Purification of an activator of human erythrocyte membrane (Ca2++Mg2+)ATPase. Biochem Biophys Res Commun. 1977 Jul 25;77(2):678–687. doi: 10.1016/s0006-291x(77)80032-6. [DOI] [PubMed] [Google Scholar]
  14. Mauldin D., Roufogalis B. D. A protein activator of Mg2+-dependent, Ca2+-stimulated ATPase in human erythrocyte membranes distinct from calmodulin. Biochem J. 1980 May 1;187(2):507–513. doi: 10.1042/bj1870507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Segal J., Ingbar S. H. Stimulation of 2-deoxy-D-glucose uptake in rat thymocytes in vitro by physiological concentrations of triiodothyronine, insulin, or epinephrine. Endocrinology. 1980 Nov;107(5):1354–1358. doi: 10.1210/endo-107-5-1354. [DOI] [PubMed] [Google Scholar]
  16. Segal J., Ingbar S. H. Studies of the mechanism by which 3,5,3'- triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3':5'-monophosphate. J Clin Invest. 1981 Jul;68(1):103–110. doi: 10.1172/JCI110224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Strittmatter W. J., Hirata F., Axelrod J. Increased Ca2+ -ATPase activity associated with methylation of phospholipids in human erythrocytes. Biochem Biophys Res Commun. 1979 May 14;88(1):147–153. doi: 10.1016/0006-291x(79)91709-1. [DOI] [PubMed] [Google Scholar]
  18. Valverde I., Sener A., Lebrun P., Herchuelz A., Malaisse W. J. The stimulus-secretion coupling of glucose-induced insulin release. XLVII. The possible role of calmodulin. Endocrinology. 1981 Apr;108(4):1305–1312. doi: 10.1210/endo-108-4-1305. [DOI] [PubMed] [Google Scholar]
  19. Vincenzi F. F., Larsen F. L. The plasma membrane calcium pump: regulation by a soluble Ca2+ binding protein. Fed Proc. 1980 May 15;39(7):2427–2431. [PubMed] [Google Scholar]
  20. Weiss B., Levin R. M. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. Adv Cyclic Nucleotide Res. 1978;9:285–303. [PubMed] [Google Scholar]
  21. Yoshida K., Davis P. J. Estimation of intracellular free triiodothyronine in man. J Clin Endocrinol Metab. 1980 Apr;50(4):667–669. doi: 10.1210/jcem-50-4-667. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES